FI114852B - Antimikrobisena aineena käytettävä hapotettu nitraatti - Google Patents

Antimikrobisena aineena käytettävä hapotettu nitraatti Download PDF

Info

Publication number
FI114852B
FI114852B FI963232A FI963232A FI114852B FI 114852 B FI114852 B FI 114852B FI 963232 A FI963232 A FI 963232A FI 963232 A FI963232 A FI 963232A FI 114852 B FI114852 B FI 114852B
Authority
FI
Finland
Prior art keywords
pharmaceutically acceptable
acidifying agent
nitrate
nitrite
dosage form
Prior art date
Application number
FI963232A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI963232A (fi
FI963232A0 (fi
Inventor
Nigel Benjamin
Hamish Dougall
Original Assignee
Univ Aberdeen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9403284A external-priority patent/GB9403284D0/en
Priority claimed from GB9404365A external-priority patent/GB9404365D0/en
Application filed by Univ Aberdeen filed Critical Univ Aberdeen
Publication of FI963232A0 publication Critical patent/FI963232A0/fi
Publication of FI963232A publication Critical patent/FI963232A/fi
Application granted granted Critical
Publication of FI114852B publication Critical patent/FI114852B/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
FI963232A 1994-02-21 1996-08-16 Antimikrobisena aineena käytettävä hapotettu nitraatti FI114852B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB9403284A GB9403284D0 (en) 1994-02-21 1994-02-21 Acidified nitrite as antimicrobial agent
GB9403284 1994-02-21
GB9404365 1994-03-07
GB9404365A GB9404365D0 (en) 1994-03-07 1994-03-07 Acidified nitrate as antimicrobial agent
GB9500338 1995-02-17
PCT/GB1995/000338 WO1995022335A1 (en) 1994-02-21 1995-02-17 Acidified nitrite as an antimicrobial agent

Publications (3)

Publication Number Publication Date
FI963232A0 FI963232A0 (fi) 1996-08-16
FI963232A FI963232A (fi) 1996-09-12
FI114852B true FI114852B (fi) 2005-01-14

Family

ID=26304368

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963232A FI114852B (fi) 1994-02-21 1996-08-16 Antimikrobisena aineena käytettävä hapotettu nitraatti

Country Status (17)

Country Link
EP (1) EP0746327B1 (no)
JP (1) JP3875262B2 (no)
KR (1) KR100385297B1 (no)
CN (1) CN1145491C (no)
AT (1) ATE264685T1 (no)
AU (1) AU693851B2 (no)
BR (1) BR9507099A (no)
CA (1) CA2183549C (no)
CZ (1) CZ286286B6 (no)
DE (1) DE69532921T2 (no)
DK (1) DK0746327T3 (no)
ES (1) ES2218541T3 (no)
FI (1) FI114852B (no)
NO (1) NO311494B1 (no)
PL (1) PL180769B1 (no)
PT (1) PT746327E (no)
WO (1) WO1995022335A1 (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9804469D0 (en) * 1998-03-02 1998-04-29 Univ Aberdeen Antiviral composition
US6709681B2 (en) 1995-02-17 2004-03-23 Aberdeen University Acidified nitrite as an antimicrobial agent
SE9700617D0 (sv) * 1997-02-21 1997-02-21 Kjell Alving New composition
US6682732B1 (en) 1998-08-28 2004-01-27 The University Of Bath Treatment of lesions
GB9905425D0 (en) * 1999-03-09 1999-05-05 Queen Mary & Westfield College Pharmaceutical composition
GB0021317D0 (en) * 2000-08-30 2000-10-18 Queen Mary & Westfield College Transdermal pharmaceutical delivery composition
GB0022084D0 (en) * 2000-09-08 2000-10-25 Univ Aberdeen Treatment of multiply antibiotic-resistant organisms
US6432077B1 (en) * 2000-12-26 2002-08-13 Sensormedics Corporation Device and method for treatment of surface infections with nitric oxide
GB0119011D0 (en) * 2001-08-03 2001-09-26 Univ Aberdeen Treatment of nail infections
DK1455888T3 (da) 2001-08-29 2009-08-24 Pharmakodex Ltd Topisk indgivelsesindretning
GB0125222D0 (en) * 2001-10-19 2001-12-12 Barts & London Nhs Trust Composition for the treatment of microbial infections
ES2294543T3 (es) 2003-07-09 2008-04-01 The Government Of The United States Of America, As Represented By The Secretary, Department Of Heal Uso de sales de nitrilo para el tratamiento de afecciones cardiovasculares.
JP2008529626A (ja) * 2005-02-11 2008-08-07 ノーラブズ エービー 皮膚真菌症、特に爪真菌症を治療するデバイスおよびその製造方法
US8557300B2 (en) 2005-05-19 2013-10-15 University Of Cincinnati Methods for treating bacterial respiratory tract infections in an individual using acidified nitrite
EP3556401A1 (en) 2005-05-27 2019-10-23 The University of North Carolina at Chapel Hill Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
GB0604319D0 (en) * 2006-03-03 2006-04-12 Optinose As Nasal delivery
GB0607402D0 (en) * 2006-04-12 2006-05-24 Barts & London Nhs Trust Therapeutic composition and use
GB0618711D0 (en) * 2006-09-22 2006-11-01 Univ Exeter Agricultural treatment
WO2011022652A1 (en) 2009-08-21 2011-02-24 Novan, Inc. Topical gels
BR112012003804B1 (pt) 2009-08-21 2019-02-19 Novan, Inc. Curativo para ferimentos, método para formar um curativo para ferimentos, e, kit de curativo para ferimento
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
WO2012118829A2 (en) 2011-02-28 2012-09-07 Novan, Inc. Tertiary s-nitrosothiol-modified nitricoxide-releasing xerogels and methods of using the same
RU2016106303A (ru) * 2013-10-31 2017-12-05 Ориджин, Инк. Способы применения оксида азота (ii) в состоянии плазмы для лечения медицинских состояний и заболеваний
CA2950314A1 (en) * 2014-06-13 2015-12-17 Origin, Inc. Veterinary methods for using nitric oxide in a plasma state to treat medical conditions and diseases in animals
KR20170117380A (ko) * 2014-12-05 2017-10-23 캔 테크놀로지스 인코포레이티드 동물 사료 보충제 및 방법
KR20200027951A (ko) 2017-06-23 2020-03-13 캔 테크놀로지스 인코포레이티드 육류 품질 개선 방법
CA3142101A1 (en) 2019-06-04 2020-12-10 Thirty Holdings Limited Methods and compositions for generating nitric oxide and uses thereof
GB2599818B (en) 2019-06-04 2024-01-31 Thirty Respiratory Ltd Methods and compositions for generating nitric oxide and uses thereof to deliver nitric oxide via the respiratory tract
JP2023526584A (ja) 2020-04-23 2023-06-22 サーティー レスピラトリー リミテッド Sars-cov及びsars-cov-2の治療に使用するための一酸化窒素または一酸化窒素放出組成物
JP2023526583A (ja) 2020-04-23 2023-06-22 サーティー レスピラトリー リミテッド 結核を治療及び抑制するための方法及び組成物
GB202101543D0 (en) 2021-02-04 2021-03-24 Thirty Respiratory Ltd Vaping e-liquid composition and the use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4191750A (en) * 1976-03-08 1980-03-04 Milton Hodosh Method for treating canker sores
JPS5985278A (ja) * 1982-11-05 1984-05-17 Agency Of Ind Science & Technol 食品の保存方法及び保存材
JPH0622540B2 (ja) * 1985-12-18 1994-03-30 株式会社祥光化学研究所 消臭抗菌能を有する構造物

Also Published As

Publication number Publication date
FI963232A (fi) 1996-09-12
JP3875262B2 (ja) 2007-01-31
PL316033A1 (en) 1996-12-23
DK0746327T3 (da) 2004-05-10
PT746327E (pt) 2004-06-30
CA2183549C (en) 2006-09-12
EP0746327B1 (en) 2004-04-21
NO311494B1 (no) 2001-12-03
ATE264685T1 (de) 2004-05-15
CZ245696A3 (en) 1997-01-15
CN1145491C (zh) 2004-04-14
CZ286286B6 (cs) 2000-03-15
CN1144484A (zh) 1997-03-05
FI963232A0 (fi) 1996-08-16
CA2183549A1 (en) 1995-08-24
ES2218541T3 (es) 2004-11-16
AU1669995A (en) 1995-09-04
NO963446D0 (no) 1996-08-19
PL180769B1 (pl) 2001-04-30
AU693851B2 (en) 1998-07-09
KR100385297B1 (ko) 2003-10-10
NO963446L (no) 1996-10-21
WO1995022335A1 (en) 1995-08-24
DE69532921T2 (de) 2005-04-14
BR9507099A (pt) 1997-09-16
JPH09508921A (ja) 1997-09-09
EP0746327A1 (en) 1996-12-11
DE69532921D1 (de) 2004-05-27

Similar Documents

Publication Publication Date Title
FI114852B (fi) Antimikrobisena aineena käytettävä hapotettu nitraatti
US6709681B2 (en) Acidified nitrite as an antimicrobial agent
Carlsson et al. Effects of pH, nitrite, and ascorbic acid on nonenzymatic nitric oxide generation and bacterial growth in urine
EP1917959B1 (en) New medical use of alfa-ketoglutarate
KR101610791B1 (ko) 알파­케토글루타레이트의 의약 용도
US20050143321A1 (en) Composition with stabilized redox properties and method of stabilization of redox properties
US10821093B2 (en) Antibacterial microelement chelates and the use thereof in animal feeds
Devhare et al. Acid neutralizing capacity and antimicrobial potential of selected solvent extract from various indigenous plants
JP2003277203A (ja) フロロタンニン類を主成分とする抗菌剤
Caufield et al. In vitro susceptibility of Streptococcus mutans 6715 to iodine and sodium fluoride, singly and in combination, at various pH values
CN108992437B (zh) 月桂酰精氨酸乙酯作为兽用抗菌剂的用途
Brook et al. Oral ofloxacin therapy of Pseudomonas aeruginosa sepsis in mice after irradiation
El-Kholany et al. Spectrophotometric and biological studies for the interaction of rifaximin with Co, Cu, Fe and vitamin C
JPH06145066A (ja) 化学療法剤の作用増強並びに感染症予防及び治療用の医薬組 成物
BG62354B1 (bg) Използване на българско розово масло като улцеропротективносредство

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 114852

Country of ref document: FI